Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance. Magnetic resonance imaging clinics of North America Choi, H. H., Rodgers, S. K., Khurana, A., Nelson, L. W., Kamaya, A. 2021; 29 (3): 279-290

Abstract

Ultrasound plays a vital role in the evaluation of patients with chronic liver disease and in hepatocellular carcinoma (HCC) surveillance in populations at risk for developing HCC. Semiannual ultrasound for HCC surveillance is universally recommended by all liver societies around the world. Advanced ultrasound techniques, such as elastography and contrast-enhanced ultrasound, offer additional benefits in imaging evaluation of chronic liver disease. Major benefits of ultrasound include its high safety profile and relatively low cost.

View details for DOI 10.1016/j.mric.2021.05.005

View details for PubMedID 34243917